Acepodia (ROCO:6976) EV-to-EBIT : -12.00 (As of May. 23, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Acepodia EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Acepodia's Enterprise Value is NT$9,742.87 Mil. Acepodia's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-811.70 Mil. Therefore, Acepodia's EV-to-EBIT for today is -12.00.

The historical rank and industry rank for Acepodia's EV-to-EBIT or its related term are showing as below:

ROCO:6976' s EV-to-EBIT Range Over the Past 10 Years
Min: -15.29 Med: -12.79 Max: -11.13
Current: -12

During the past 4 years, the highest EV-to-EBIT of Acepodia was -11.13. The lowest was -15.29. And the median was -12.79.

ROCO:6976's EV-to-EBIT is ranked worse than
100% of 422 companies
in the Biotechnology industry
Industry Median: 10.345 vs ROCO:6976: -12.00

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Acepodia's Enterprise Value for the quarter that ended in Jun. 2023 was NT$0.00 Mil. Acepodia's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-811.70 Mil. Acepodia's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was %.

Acepodia EV-to-EBIT Historical Data

The historical data trend for Acepodia's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia EV-to-EBIT Chart

Acepodia Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

-16.51

Acepodia Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial			-	-	-	-	-16.51

Competitive Comparison of Acepodia's EV-to-EBIT

For the Biotechnology subindustry, Acepodia's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acepodia's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acepodia's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Acepodia's EV-to-EBIT falls into.

Acepodia EV-to-EBIT Calculation

Acepodia's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	9742.872	/	-811.699
	=	-12.00

Acepodia's current Enterprise Value is NT$9,742.87 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acepodia's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-811.70 Mil.

Acepodia (ROCO:6976) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Acepodia's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	-811.699	/	0
	=	%

Acepodia's Enterprise Value for the quarter that ended in Jun. 2023 was NT$0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acepodia's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-811.70 Mil.

Acepodia EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Acepodia's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Acepodia (ROCO:6976) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175

Website

https://www.acepodia.com

Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia (ROCO:6976) Headlines

No Headlines